Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (-)-(6r,7r)-2,2-dimethylpropionyloxymethyl 7-((z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido)-3-((z)-2-(4-methylthiazol-5-yl)ethenyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
2. 7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(2-(4-methylthiazol-5-yl)ethenyl)cephem-4-carboxylic Acid Pivaloyloxymethyl Ester
3. Cdtr-pi
4. Me 1207
5. Me-1207
6. Spectracef
1. Spectracef
2. 117467-28-4
3. Cefditoren Pivaloyloxymethyl Ester
4. Cdtr-pi
5. Meiact
6. Cefditoren (pivoxil)
7. Cefditoren Pivoxil [jan]
8. Me-1207
9. Cefditorin Pivoxil
10. Me1207
11. Cefditoren Pivoxil Hcl
12. 78tha212dh
13. Cefditorin
14. Chebi:560555
15. Me 1207
16. Nsc-759098
17. 2,2-dimethylpropanoyloxymethyl (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
18. Cefditoren Pi Voxil
19. Cefditoren-pivoxil
20. [(2,2-dimethylpropanoyl)oxy]methyl (6r,7r)-7-{[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
21. [(2,2-dimethylpropanoyl)oxy]methyl 7beta-(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido-3-[(z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-3,4-didehydrocepham-4-carboxylic Acid
22. 1448435-17-3
23. Pivaloyloxymethyl (+)-(6r,7r)-7-{[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
24. Ccris 7768
25. Unii-78tha212dh
26. Spectracef (tn)
27. Ncgc00095175-01
28. Meiact (tn)
29. Mfcd00933166
30. Dsstox_cid_28669
31. Dsstox_rid_82939
32. Dsstox_gsid_48743
33. Schembl182876
34. Chembl454446
35. Cefditoren Pivoxil [usan:jan]
36. Dtxsid2048743
37. Cefditoren Pivoxil [usan]
38. Cefditoren Pivoxil (jp17/usan)
39. Cefditoren Pivoxil [vandf]
40. Cefditoren Pivoxil [mart.]
41. Cefditoren Pivoxil [who-dd]
42. Tox21_113197
43. Hy-17452a
44. S1768
45. Akos025311444
46. Ccg-270254
47. Cs-1949
48. Nsc 759098
49. Cefditoren Pivoxil [orange Book]
50. Ncgc00095175-08
51. (pivaloyloxy)methyl (6r,7r)-7-((z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((z)-2-(4-methylthiazol-5-yl)vinyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
52. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-((1z)-2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-,2,2-dimethyl-1-oxopropoxy)methyl Ester, (6r,7r)-
53. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester, (6r-(3(z),6-alpha,7-beta-(z)))-
54. As-12951
55. B2086
56. Cas-117467-28-4
57. Cefditoren Pivaloyloxymethyl Ester [mi]
58. D01628
59. Ab01274730-01
60. Ab01274730_02
61. 467c284
62. Brd-k72167406-001-03-9
63. (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-((z)-2-(4-methyl-5-thiazolyl)vinyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate Pivaloyloxy Methyl Ester, 7(sup 2)-(z)-(o-methyloxime)
64. (6r,7r)-(pivaloyloxy)methyl 7-((z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((z)-2-(4-methylthiazol-5-yl)vinyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
65. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7(((2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-((1z)-2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester, (6r,7r)-
Molecular Weight | 620.7 g/mol |
---|---|
Molecular Formula | C25H28N6O7S3 |
XLogP3 | 4.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 12 |
Exact Mass | 620.11816077 g/mol |
Monoisotopic Mass | 620.11816077 g/mol |
Topological Polar Surface Area | 257 Ų |
Heavy Atom Count | 41 |
Formal Charge | 0 |
Complexity | 1160 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Spectracef |
PubMed Health | Cefditoren Pivoxil (By mouth) |
Drug Classes | Antibiotic |
Drug Label | SPECTRACEF tablets contain cefditoren pivoxil, a semi-synthetic cephalosporin antibiotic for oral administration. It is a prodrug which is hydrolyzed by esterases during absorption, and the drug is distributed in the circulating blood as active cef... |
Active Ingredient | Cefditoren pivoxil |
Dosage Form | Tablet |
Route | Oral |
Strength | 200mg; 400mg |
Market Status | Prescription |
Company | Vansen Pharma |
2 of 2 | |
---|---|
Drug Name | Spectracef |
PubMed Health | Cefditoren Pivoxil (By mouth) |
Drug Classes | Antibiotic |
Drug Label | SPECTRACEF tablets contain cefditoren pivoxil, a semi-synthetic cephalosporin antibiotic for oral administration. It is a prodrug which is hydrolyzed by esterases during absorption, and the drug is distributed in the circulating blood as active cef... |
Active Ingredient | Cefditoren pivoxil |
Dosage Form | Tablet |
Route | Oral |
Strength | 200mg; 400mg |
Market Status | Prescription |
Company | Vansen Pharma |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20292
Submission : 2007-02-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25086
Submission : 2011-06-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23544
Submission : 2010-04-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17482
Submission : 2004-06-22
Status : Inactive
Type : II
Registration Number : 302MF10072
Registrant's Address : 2-4-16 Kyobashi, Chuo-ku, Tokyo
Initial Date of Registration : 2020-06-26
Latest Date of Registration :
Registrant Name : Boryeong Co., Ltd.
Registration Date : 2020-11-13
Registration Number : 20201113-209-J-519
Manufacturer Name : Meiji Seika Pharma Co., Ltd.
Manufacturer Address : 2890, Kitagata, Kitagata-cho, Motosu-gun, Gifu-ken, Japan
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19011
Submission : 2005-12-07
Status : Inactive
Type : II
Registration Number : 219MF10254
Registrant's Address : 343, Sapyeong-daero, Seocho-gu, Seoul, Korea
Initial Date of Registration : 2007-08-06
Latest Date of Registration :
Registrant Name : Jeil Pharmaceutical Co., Ltd.
Registration Date : 2019-12-19
Registration Number : 20191219-209-J-509
Manufacturer Name : Jeil Pharmaceutical Co., Ltd.
Manufacturer Address : 7 Cheonggang-ga-chang-ro, Baekam-myeon, Cheoin-gu, Yongin-si, Gyeonggi-do (Building B and others)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
ANALYTICAL
ABOUT THIS PAGE
77
PharmaCompass offers a list of Cefditoren Pivoxil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cefditoren Pivoxil manufacturer or Cefditoren Pivoxil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefditoren Pivoxil manufacturer or Cefditoren Pivoxil supplier.
PharmaCompass also assists you with knowing the Cefditoren Pivoxil API Price utilized in the formulation of products. Cefditoren Pivoxil API Price is not always fixed or binding as the Cefditoren Pivoxil Price is obtained through a variety of data sources. The Cefditoren Pivoxil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A ME 1207 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ME 1207, including repackagers and relabelers. The FDA regulates ME 1207 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ME 1207 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of ME 1207 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A ME 1207 supplier is an individual or a company that provides ME 1207 active pharmaceutical ingredient (API) or ME 1207 finished formulations upon request. The ME 1207 suppliers may include ME 1207 API manufacturers, exporters, distributors and traders.
click here to find a list of ME 1207 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A ME 1207 DMF (Drug Master File) is a document detailing the whole manufacturing process of ME 1207 active pharmaceutical ingredient (API) in detail. Different forms of ME 1207 DMFs exist exist since differing nations have different regulations, such as ME 1207 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A ME 1207 DMF submitted to regulatory agencies in the US is known as a USDMF. ME 1207 USDMF includes data on ME 1207's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The ME 1207 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of ME 1207 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The ME 1207 Drug Master File in Japan (ME 1207 JDMF) empowers ME 1207 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the ME 1207 JDMF during the approval evaluation for pharmaceutical products. At the time of ME 1207 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of ME 1207 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a ME 1207 Drug Master File in Korea (ME 1207 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of ME 1207. The MFDS reviews the ME 1207 KDMF as part of the drug registration process and uses the information provided in the ME 1207 KDMF to evaluate the safety and efficacy of the drug.
After submitting a ME 1207 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their ME 1207 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of ME 1207 suppliers with KDMF on PharmaCompass.
ME 1207 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ME 1207 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ME 1207 GMP manufacturer or ME 1207 GMP API supplier for your needs.
A ME 1207 CoA (Certificate of Analysis) is a formal document that attests to ME 1207's compliance with ME 1207 specifications and serves as a tool for batch-level quality control.
ME 1207 CoA mostly includes findings from lab analyses of a specific batch. For each ME 1207 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ME 1207 may be tested according to a variety of international standards, such as European Pharmacopoeia (ME 1207 EP), ME 1207 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ME 1207 USP).